Loading...
Last update:  December 3, 2017
19:22 +1GMT

Allergenic Molecule  Ara h 3Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.5 - Atopic Dermatitis, Diagnosed2014NetherlandsIgE2117.60020140331, Rockmann H
5.3.1 - Source Exposed (Symptoms, IgE)2014GermanyIgE3278.12020140225, Lopes de Oliveira LC
3.2.1 - Source Sensitized (IgE)2014GermanyIgE2755.55020140225, Lopes de Oliveira LC
5.3.1 - Source Exposed (Symptoms, IgE)2014JapanIgE1687.50020140623, Nozawa A
5.7.2 - Source Exposed (Provocation Test - Ingestion)2013Sweden / USAIgE16734.20020130113, Lieberman JA
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.90020130912, Lacerda Araujo LM
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE761.30020131020, van Rhijn BD
5.7.2 - Source Exposed (Provocation Test - Ingestion)2013ItalyIgE4823.00020131128, Calamelli E
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013NetherlandsIgE4339.54020130429, Aalberse JA
5.1.1 - Source Exposed (Symptoms)2013NetherlandsIgE3756.76020130428, Klemans RJ
3.2.1 - Source Sensitized (IgE)2013ItalyIgE2417.00020131128, Calamelli E
5.3.1 - Source Exposed (Symptoms, IgE)2013ItalyIgE2429.00020131128, Calamelli E
3.1.4 - Source Sensitized (SPT, IgE)2013NetherlandsIgE2227.27020130429, Aalberse JA
3.2.1 - Source Sensitized (IgE)2013ThailandIgE219.50020131011, Suratannon N
5.3.1 - Source Exposed (Symptoms, IgE)2013ThailandIgE1921.10020131011, Suratannon N
3.2.1 - Source Sensitized (IgE)2013SloveniaIgE166.25020131106, Homsak M
5.3.1 - Source Exposed (Symptoms, IgE)2013SloveniaIgE1163.63020131106, Homsak M
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9912.12020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE961.04020120528, Patelis A
3.1.1 - Source Sensitized (SPT)2012SpainIgE798.86020121016, Javaloyes G
3.1.4 - Source Sensitized (SPT, IgE)2012SpainIgE687.40020120726, Pedrosa M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012SpainIgE5543.60020120726, Pedrosa M
5.3.2 - Source Exposed (Symptoms, high IgE)2012TaiwanIgE2962.10020120319, Lin YT
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1000.00020111214, Zheng YW
5.3.1 - Source Exposed (Symptoms, IgE)2011SwedenIgE7444.59020110701, Moverare R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011NetherlandsIgE1266.66020110304, Vissers YM
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2011NetherlandsIgE80.00020110304, Vissers YM
5.7.2 - Source Exposed (Provocation Test - Ingestion)2010FranceIgE16661.45020100923, Codrenau F
3.2.1 - Source Sensitized (IgE)2010SwedenIgE10025.00020100212, Asarnoj A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8611.62020101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010FranceIgE6116.39020100923, Codrenau F
5.3.1 - Source Exposed (Symptoms, IgE)2010SpainIgE5016.00020101124, Vereda A
4.1.5 - Heterologous Source Sensitized (IgE)2010SwedenIgE500.00020100212, Asarnoj A
5.3.1 - Source Exposed (Symptoms, IgE)2010SwedenIgE3537.10020101124, Vereda A
5.3.1 - Source Exposed (Symptoms, IgE)2010United StatesIgE3056.70020101124, Vereda A
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2010BelgiumIgE2035.00020100628, Verweij MM
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE370.00020090826, Ebo DG
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009ItalyIgE210.00020090808, Krause S
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyBPT205.00020091005, Ott H
5.7.2 - Source Exposed (Provocation Test - Ingestion)2007NetherlandsIgE2050.00020070615, Flinterman AE
5.7.2 - Source Exposed (Provocation Test - Ingestion)2007NetherlandsSPT955.50020070615, Flinterman AE
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2006FranceIgE3020.00020060630, Astier C
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2006FranceSPT3027.00020060630, Astier C
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2004NetherlandsIgE (IB)3237.50020040416, Koppelman SJ
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2004Netherlands / SwitzerlandIgE1752.90020041204, Mittag D
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)1999GermanyIgE (IB)4053.0001999, Kleber-Janke T
5.7.2 - Source Exposed (Provocation Test - Ingestion)1999United StatesIgE1844.4001999, Rabjohn P
Developed by
Panservice